Skip to content

Jerash Holdings (US), Inc. JRSH Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

V.F. Corporation logo
V.F. CorporationVFC
FDP
FDPFDP

Other financials

Income statement

See full
Revenue$41.8M+18.0%
Gross profit$7.0M+31.0%
Operating income$1.9M+175%
Net income$1.2M+20,261%
EPS (diluted)$0.09

Balance sheet

See full
Cash & equivalents$11.5M-22.5%
Total debt$365.0K-45.5%
Total equity$63.6M+0.7%
Total assets$84.2M+5.5%

Cash flow

See full
Operating cash flow-$3.8M-26.7%
CapEx$92.0K-35.8%
Free cash flow-$3.9M-23.8%

Valuation

See full
Market cap$61.09M+36.1%
Enterprise value$50M+25.3%
P/E34×-21.1×
P/S0.4×+0.1×

Profitability

See full
Gross margin16.2%+2.7pp
Operating margin2.9%+2.2pp
Net margin1.2%+0.7pp
FCF margin-2.9%

Returns & leverage

See full
Return on equity2.8%+1.7pp
Debt / equity0.0×
Current ratio2.8×-0.3×

Where this comes from

Reported directly by Jerash Holdings (US), Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Jerash Holdings (US), Inc.’s 10-Q, filed February 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jerash Holdings (US), Inc.'s common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jerash Holdings (US), Inc.'s common stock, shares authorized (in shares)?
Jerash Holdings (US), Inc. (JRSH) reported common stock, shares authorized (in shares) of $30M in Q4 2025.
How has Jerash Holdings (US), Inc.'s common stock, shares authorized (in shares) changed year-over-year?
Jerash Holdings (US), Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $30M to $30M.
What is the long-term trend for Jerash Holdings (US), Inc.'s common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), Jerash Holdings (US), Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $30M to $30M.